Explore

Brazil's HIV Advocates Foresee USAID Funding Cuts, Emphasizing Self-Reliance

Brazil's HIV Advocates Foresee USAID Funding Cuts, Emphasizing Self-Reliance

Brazil's HIV advocates have long anticipated a reduction in USAID funding, a development they have been preparing for by ensuring the country's health system operates independently of foreign aid. Brazil's Unified Health System, which has been robust enough to eliminate HIV transmission to newborns by 2025, is a testament to this independence. However, challenges remain, such as limited access to the latest HIV preventions and treatments due to ongoing negotiations with pharmaceutical companies. The right to healthcare, enshrined in Brazil's constitution since 1988, has been pivotal in integrating HIV prevention and treatment into the national health agenda. Advocates like Juliana Cesar from the NGO Gestos have been vocal about the need for financial independence, encouraging other nations to adopt similar measures, such as Brazil's Financial Transaction Tax, which funded public health initiatives. Despite these efforts, the tax is being phased out as Brazil shifts politically to the right.

Gilead's HIV Drug Lenacapavir Faces Pricing Challenges in Latin America

Gilead's HIV Drug Lenacapavir Faces Pricing Challenges in Latin America

Gilead Sciences has developed a new HIV drug, lenacapavir, which is nearly 100% effective in preventing HIV infection with just two shots a year. Despite its potential to significantly reduce HIV transmission, the drug's high cost poses a barrier to access in Latin American countries where it was tested. While Gilead has agreed to license generic versions of the drug at a reduced price in 120 low- and middle-income countries, many Latin American nations, classified as upper-middle-income, do not qualify for these discounts. This has led to protests and criticism at the International AIDS Society Conference in Rio De Janeiro, where activists and officials from countries like Brazil have expressed frustration over stalled negotiations with Gilead. The company is accused of demanding prices significantly higher than those offered to other countries with similar economic statuses.

USAID Funding Cuts Threaten Global Access to New HIV Prevention Drug

USAID Funding Cuts Threaten Global Access to New HIV Prevention Drug

At the Aids 2026 Conference in Rio de Janeiro, experts highlighted the potential of lenacapavir, an injectable HIV prevention drug, to significantly reduce new HIV cases globally. The World Health Organization (WHO) has recommended prioritizing the expansion of lenacapavir access due to its effectiveness and the convenience of requiring only two injections annually. However, the dissolution of USAID, which previously provided a substantial portion of global HIV prevention funding, has led to a dramatic decline in investment. This reduction in funding is impacting the availability of the drug and the ability of organizations to reach those in need, particularly in regions facing poverty, stigma, or geographical barriers.

Gilead Faces Pricing Controversy Over HIV Drug Lenacapavir in Latin America

Gilead Faces Pricing Controversy Over HIV Drug Lenacapavir in Latin America

Gilead Sciences is facing criticism over the pricing of its HIV prevention drug, lenacapavir, in Latin America. Despite the drug's potential to significantly reduce HIV infections, its high cost in countries like Brazil, Mexico, Argentina, and Peru has sparked protests. These countries, classified as 'upper-middle income,' do not qualify for the reduced price offered to lower-income nations. Activists and officials argue that the pricing strategy is unjust, given the drug's life-saving potential. Brazil's health minister has criticized Gilead for demanding prices significantly higher than those in other countries with similar economic status.

WHO Criticizes Ultra-Processed Food Companies for Hindering Health Initiatives

WHO Criticizes Ultra-Processed Food Companies for Hindering Health Initiatives

The World Health Organization (WHO) has accused major ultra-processed food corporations of obstructing global efforts to combat the obesity crisis by suing governments that implement health measures. WHO Director General Tedros Adhanom Ghebreyesus highlighted that these lawsuits delay vital public health policies, costing countries billions in healthcare and legal expenses. The investigation found that companies like Coca-Cola, PepsiCo, and Kellogg's have filed numerous lawsuits against health policies in countries such as the US, UK, and Brazil. Despite public claims of supporting healthier diets, these companies are actively working to overturn or weaken regulations aimed at reducing junk food consumption.

US Government Faces Backlash Over Mislabeling African Countries on Map

US Government Faces Backlash Over Mislabeling African Countries on Map

During a major health conference in Brazil, the US State Department presented a map that inaccurately labeled African countries, causing an online stir. The map, shown at the AIDS 2026 conference, misplaced countries like Nigeria and Mozambique, leading to widespread ridicule. The State Department admitted the error, attributing it to a hasty edit by a team member. The map, which contained a watermark indicating it was created with OpenAI tools, was criticized for its inaccuracies. Despite the error, the State Department emphasized its commitment to fighting AIDS.

DR Congo Ebola Epidemic Becomes World's Second Largest Outbreak

DR Congo Ebola Epidemic Becomes World's Second Largest Outbreak

The Ebola epidemic in the Democratic Republic of the Congo (DRC) has become the world's second largest outbreak, with over 3,500 confirmed cases. The outbreak, caused by the Bundibugyo strain of the virus, has resulted in 1,556 deaths, with a case fatality rate of 44.1 percent. The rapid spread of the virus has prompted calls for increased global attention and resources to contain the epidemic.

The Victory That Put U.S. Women's Soccer on the Olympic Map

The Victory That Put U.S. Women's Soccer on the Olympic Map

The 1996 Summer Olympics in Atlanta marked a historic moment in sports history with the introduction of the women's football tournament. This event...

State Department's Mislabeling of African Countries at AIDS Conference Sparks Controversy

State Department's Mislabeling of African Countries at AIDS Conference Sparks Controversy

During a global conference in Brazil, the U.S. State Department presented a map of Africa that incorrectly labeled every country, causing significant confusion among attendees. The map was displayed during a presentation on new health agreements at the AIDS 2026 conference in Rio de Janeiro. The map, which contained an artificial intelligence watermark indicating it was created using OpenAI tools, showed countries like Nigeria and Mozambique in incorrect locations. The State Department has taken full responsibility for the error, attributing it to a last-minute change in the presentation slides. Despite the map mishap, the State Department emphasized that the discussions at the conference were constructive and reaffirmed its commitment to fighting AIDS.

Paraguay Requests Return of War Trophies from Brazil Amid Diplomatic Tensions

Paraguay Requests Return of War Trophies from Brazil Amid Diplomatic Tensions

Paraguay's Vice President Pedro Alliana formally requested the return of war trophies from Brazil, including cannons and historical documents from the Paraguayan War (1864-1870). The request was made to Brazilian Ambassador José Antonio Marcondes following comments by President Luiz Inácio Lula da Silva about Paraguay's historical invasion of Brazil. The Paraguayan government emphasized the importance of addressing historical issues with prudence and maintaining a cooperative relationship with Brazil. Despite the diplomatic tension, both countries reaffirmed their commitment to cooperation, citing partnerships like Itaipu and Mercosur.

Nature Conference on Infectious Diseases to Convene Global Experts at MAHE, Manipal

Nature Conference on Infectious Diseases to Convene Global Experts at MAHE, Manipal

The Manipal Academy of Higher Education (MAHE) in India is set to host a significant Nature Conference on infectious diseases from October 14-16, 2026. This event will bring together international experts to discuss challenges related to infectious diseases, antimicrobial resistance, and pandemic preparedness. Organized in collaboration with Nature Medicine, Nature Microbiology, and other Nature journals, the conference aims to foster interdisciplinary dialogue and accelerate scientific solutions for global health resilience. The conference will feature keynote addresses, panel discussions, and networking opportunities, focusing on equitable access to diagnostics, therapeutics, and vaccines, particularly for low- and middle-income countries.

US Apologises for Displaying Incorrect Africa Map at AIDS Conference

US Apologises for Displaying Incorrect Africa Map at AIDS Conference

The US State Department has apologized for displaying an incorrect map of Africa during an AIDS conference in Brazil. The map inaccurately located six African countries, including Nigeria and Mozambique. The error was revealed by conference participants and reported by Reuters. The State Department attributed the mistake to a last-minute modification of the slideshow. Despite the error, the US highlighted constructive discussions at the conference, which focused on global health assistance amid reduced US aid budgets.